An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who's been using Mounjaro (a prescription drug) for about ten weeks says they had a chest infection three weeks ago and since then have felt unusually exhausted and unwell. They went up in dose from 2.5 mg to 7.5 mg over that time and now wonder whether the drug could be causing prolonged lethargy instead of—or on top of—symptoms from the infection. Mounjaro is the brand name for tirzepatide. It's not a "peptide" in the kitchen sense; it's a lab-made medicine that mimics hormones your gut uses to help control blood sugar and appetite. In simple terms, it tells your body to release insulin and to slow digestion a bit, and it can reduce hunger. Doctors prescribe it mainly for type 2 diabetes and sometimes for weight loss under supervision. What this one person describes is a single report, not a controlled study. From clinical trials and prescribing information, common side effects of tirzepatide include nausea, diarrhea, constipation, stomach pain, and sometimes fatigue. Fatigue is reported but is not the most common complaint, and prolonged extreme lethargy after an infection isn’t a typical pattern uniquely tied to the drug in the public data. It's also important that their dose was recently increased; side effects can be worse during dose changes. On the other hand, infections themselves—especially chest infections—can leave people feeling run down for weeks afterwards as the body recovers. Why this matters: anyone taking Mounjaro or similar medicines who notices persistent, unusual tiredness should pay attention. It could be a medication side effect, the natural recovery from an infection, an interaction with other conditions (like anemia, thyroid problems, or ongoing infection), or a combination. If the tiredness affects daily life, interferes with breathing, causes fainting, or is getting worse instead of better, it’s worth contacting the prescribing clinician to review symptoms, timing with dose changes, and whether any tests or a temporary dose hold are appropriate. Caveats and risks: one person’s report can’t prove cause and effect. Only a clinician can evaluate whether the drug, the recent infection, or another issue is the main driver. Stopping tirzepatide abruptly on your own isn’t advised without medical guidance. Also mention that some people shouldn’t take tirzepatide—people with certain histories like medullary thyroid cancer or specific pancreatitis risks need different advice—so always check with the prescriber. If symptoms are severe, sudden, or include trouble breathing, chest pain, fainting, or signs of serious infection, seek urgent care. Bottom line: feeling unusually exhausted after a chest infection could be the illness itself, a medication side effect, or both—talk to your doctor to sort it out rather than guessing.
Source: r/Mounjaro